Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -3.6 Million AUD | 42.03% |
| 2023 | -6.21 Million AUD | 50.77% |
| 2022 | -12.62 Million AUD | 29.38% |
| 2021 | -17.87 Million AUD | 33.9% |
| 2020 | -27.04 Million AUD | -418.85% |
| 2019 | 8.48 Million AUD | -10.67% |
| 2018 | 9.49 Million AUD | 253.36% |
| 2017 | 2.68 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -6.33 Million AUD | -1.98% |
| 2024 FY | -3.6 Million AUD | 42.03% |
| 2024 Q4 | -3.6 Million AUD | 43.15% |
| 2023 Q2 | -9.88 Million AUD | 21.67% |
| 2023 Q4 | -6.21 Million AUD | 37.15% |
| 2023 FY | -6.21 Million AUD | 50.77% |
| 2022 Q4 | -12.62 Million AUD | 4.8% |
| 2022 FY | -12.62 Million AUD | 29.38% |
| 2022 Q2 | -13.26 Million AUD | 25.82% |
| 2021 Q4 | -17.87 Million AUD | 27.41% |
| 2021 Q2 | -24.63 Million AUD | 8.94% |
| 2021 FY | -17.87 Million AUD | 33.9% |
| 2020 FY | -27.04 Million AUD | -418.85% |
| 2020 Q4 | -27.04 Million AUD | -334.25% |
| 2020 Q2 | 11.54 Million AUD | 36.12% |
| 2019 Q4 | 8.48 Million AUD | 0.0% |
| 2019 FY | 8.48 Million AUD | -10.67% |
| 2018 FY | 9.49 Million AUD | 253.36% |
| 2017 FY | 2.68 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 85.861% |
| Adherium Limited | -6.1 Million AUD | 40.971% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 3.838% |
| Anteris Technologies Ltd | -28.49 Million AUD | 87.356% |
| Control Bionics Limited | -19.02 Thousand AUD | -18842.908% |
| CardieX Limited | 2.74 Million AUD | 231.205% |
| Compumedics Limited | 5.08 Million AUD | 170.834% |
| Cochlear Limited | -269.9 Million AUD | 98.665% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 615.797% |
| Cyclopharm Limited | -7.49 Million AUD | 51.95% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 77.051% |
| Nova Eye Medical Limited | -2.8 Million AUD | -28.598% |
| HeraMED Limited | -799.34 Thousand AUD | -350.782% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 124.88% |
| ImpediMed Limited | -23.48 Million AUD | 84.66% |
| InhaleRx Limited | -155.54 Thousand AUD | -2216.592% |
| LBT Innovations Limited | -604 Thousand AUD | -496.576% |
| Micro-X Limited | 826.99 Thousand AUD | 535.71% |
| Neurotech International Limited | -2.11 Million AUD | -70.735% |
| OncoSil Medical Limited | -4.43 Million AUD | 18.674% |
| PolyNovo Limited | -30.52 Million AUD | 88.196% |
| Respiri Limited | 413.68 Thousand AUD | 971.021% |
| SomnoMed Limited | -15.16 Million AUD | 76.236% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 32.063% |
| Uscom Limited | -1.53 Million AUD | -135.414% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 11.747% |